Drug-related problems among older patients: Analysis of 8 years of pharmacist's interventions.

Analyse et pertinence de la prescription Drug-related problem Iatrogénie médicamenteuse Medication order review Older patient Safety Sujet âgé Sécurité

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 27 08 2020
revised: 18 12 2020
accepted: 07 02 2021
pubmed: 16 2 2021
medline: 26 10 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

To analyse the most frequent DRP over time and pharmacists' interventions made among older patients aged over 75 years old. DRP between older patients and younger patients aged 18 to 74 years and between older patients treated in geriatric wards or not were also compared. A cross-sectional observational study conducted on DRP detected by pharmacists at the university hospital centre of Lyon and prospectively recorded in the Act-IP© database from January 2008 to December 2015. A total of 56,223 DRP were investigated - 19,056 in older patients and 37,167 in younger patients. A supratherapeutic dosage was mainly reported (22.4% in older patients vs. 19.0% in younger patient) and pharmacists made interventions mostly to adjust dosage (27.3% vs. 24.2%). Physicians' acceptance was significantly lower in older patients (57.1% vs. 64.3%). DRP associated to a drug included a supratherapeutic use of acetaminophen (5.2% vs. 3.8%) and hypnotics (4.0% vs. 1.4%), medication in cardiology used without indication (1.4% vs. 0.2%) and underuse of vitamin D (1.2% vs. 0.1%). Supratherapeutic dosages were more significantly detected with a lower overall physicians' acceptance in older patients treated in general wards. This study highlights the specificity of DRP among older patients and encourages health care professionals to remain especially alert regarding older patients treated in general wards. These findings can contribute to define or adjust training needs and quality indicators to improve the daily practices of health care professionals.

Identifiants

pubmed: 33587921
pii: S0003-4509(21)00034-1
doi: 10.1016/j.pharma.2021.02.002
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

511-521

Informations de copyright

Copyright © 2021 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

F Gervais (F)

Pharmacie, Groupement hospitalier centre, Hospices civils de Lyon, Lyon, France. Electronic address: frederic.gervais@chu-lyon.fr.

T Novais (T)

Pharmacie, Groupement hospitalier centre, Hospices civils de Lyon, Lyon, France; ISPB - Facultés de pharmacie de Lyon, Université de Lyon, Université Claude-Bernard Lyon 1, Lyon, France; Université de Lyon, EA-7425 HESPER, Health Services and Performance Research, 69003 Lyon, France.

S Goutelle (S)

Pharmacie, Groupement hospitalier Nord, Hospices civils de Lyon, Lyon, France; ISPB - Facultés de pharmacie de Lyon, Université de Lyon, Université Claude-Bernard Lyon 1, Lyon, France; Université de Lyon, Université Claude-Bernard Lyon 1, UMR CNRS 5558, Laboratoire de biométrie et biologie évolutive, Villeurbanne, France.

M Chappuy (M)

Pharmacie, Groupement hospitalier centre, Hospices civils de Lyon, Lyon, France; Pharmacie, Groupement hospitalier Nord, Hospices civils de Lyon, Lyon, France.

S Parat (S)

Pharmacie, Groupement hospitalier Sud, Hospices civils de Lyon, Lyon, France.

D Cabelguenne (D)

Pharmacie, Groupement hospitalier Sud, Hospices civils de Lyon, Lyon, France.

C Mouchoux (C)

Pharmacie, Groupement hospitalier centre, Hospices civils de Lyon, Lyon, France; ISPB - Facultés de pharmacie de Lyon, Université de Lyon, Université Claude-Bernard Lyon 1, Lyon, France; INSERM U1028; CNRS UMR5292; Lyon Neuroscience Research Centre, Brain Dynamics and Cognition Team, 69000 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH